NCT05707910 2026-03-09
Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors
West China Hospital
Phase 1 Active not recruiting
West China Hospital
University of Southern California
Harbour BioMed (Guangzhou) Co. Ltd.